| Literature DB >> 31581602 |
Romain Veyron-Churlet1, Camille Locht2.
Abstract
Studies on protein-protein interactions (PPI) can be helpful for the annotation of unknown protein functions and for the understanding of cellular processes, such as specific virulence mechanisms developed by bacterial pathogens. In that context, several methods have been extensively used in recent years for the characterization of Mycobacterium tuberculosis PPI to further decipher tuberculosis (TB) pathogenesis. This review aims at compiling the most striking results based on in vivo methods (yeast and bacterial two-hybrid systems, protein complementation assays) for the specific study of PPI in mycobacteria. Moreover, newly developed methods, such as in-cell native mass resonance and proximity-dependent biotinylation identification, will have a deep impact on future mycobacterial research, as they are able to perform dynamic (transient interactions) and integrative (multiprotein complexes) analyses.Entities:
Keywords: Mycobacterium; protein–protein interactions; tuberculosis; virulence
Year: 2019 PMID: 31581602 PMCID: PMC6963305 DOI: 10.3390/pathogens8040173
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1Schematic representation of the yeast two-hybrid (Y2H) system. POI—protein of interest; AD—activating domain; BD—binding domain.
Comparison of the different techniques used to study mycobacterial protein–protein interactions (PPI).
| Methods | Contact | Membrane Proteins | Nature of the Interaction | Cellular Context | PTM and Cofactors | HTS |
|---|---|---|---|---|---|---|
| Y2H | direct | no | binary | no | no | yes |
| BACTH | direct | yes | binary | yes/no | yes/no | yes |
| M-PFC | direct | yes | binary | yes | yes | yes |
| Split-Trp | direct | yes | binary | yes | yes | yes |
| Crosslinking | direct | yes | complex | yes | yes | no |
| In-cell NMR | proximity | yes | complex | yes/no | yes/no | no |
| Biotinylation | proximity | yes | complex | yes | yes | yes |
PTM—post-translational modifications; HTS—high-throughput screening; Y2H—yeast two hybrid; BACTH—bacterial adenylate cyclase-based two-hybrid; M-PFC—mycobacterial protein fragment complementation; NMR—nuclear magnetic resonance.
Figure 2Schematic representation of the bacterial adenylate cyclase-based two-hybrid (BACTH) system. ATP—adenosine triphosphate; cAMP—cyclic adenosine monophosphate; CAP— catabolite activator protein.
Figure 3Schematic representation of the mycobacterial protein fragment complementation (M-PFC) technology. mDHFR—murine dihydrofolate reductase.
Figure 4Schematic representation of the split-Trp (or protein fragment complementation assay) technology.
Figure 5Schematic representation of in vivo crosslinking.
Figure 6Schematic representation of the proximity-dependent biotinylation assay.